Price
Target price
€11.70
€11.70
0.860%
0.1
0.860%
€14.80
12.12.25 / Stuttgart Stock Exchange
WKN: 659157 / Symbol: RDY / Name: Dr. Reddy's / Stock / Pharmaceuticals / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Dr. Reddy's Laboratories Ltd. ADR Stock
Dr. Reddy's Laboratories Ltd. ADR gained 0.860% compared to yesterday.
The community is currently still undecided about Dr. Reddy's Laboratories Ltd. ADR with 2 Buy predictions and 0 Sell predictions.
As a result the target price of 14 € shows a slightly positive potential of 19.66% compared to the current price of 11.7 € for Dr. Reddy's Laboratories Ltd. ADR.
Criterium "Brand" is seen as the biggest plus for Dr. Reddy's Laboratories Ltd. ADR stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Dr. Reddy's Laboratories Ltd. ADR in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Dr. Reddy's Laboratories Ltd. ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Dr. Reddy's Laboratories Ltd. ADR | 0.860% | -3.306% | -1.681% | -13.971% | -21.477% | -77.282% | -78.919% |
| Almirall S.A. | 0.910% | 2.160% | 7.120% | 59.422% | 63.760% | 40.329% | 22.366% |
| Orion Corp. B | -0.410% | 1.151% | 2.500% | 44.808% | 43.290% | 22.804% | 62.957% |
| Sihuan Pharmaceutical Holdings Group Ltd. | 1.450% | -3.448% | -10.256% | 71.779% | 83.007% | 23.894% | 78.344% |
Comments
Dr. Reddy's Laboratories Limited (NYSE: RDY) was upgraded by analysts at Hsbc Global Res from a "hold" rating to a "strong-buy" rating.
Show more
Ratings data for RDY provided by MarketBeat
Dr. Reddy's Laboratories Limited (NYSE: RDY) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating. They now have a $16.90 price target on the stock, up previously from $14.44.
Show more
Ratings data for RDY provided by MarketBeat
Dr. Reddy's Laboratories Limited (NYSE: RDY) had its price target lowered by analysts at Barclays PLC from $17.40 to $17.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for RDY provided by MarketBeat